Company Filing History:
Years Active: 2021
Title: Yingqing Wang: Innovator in Bromodomain Recognition Protein Inhibitors
Introduction
Yingqing Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of inhibitors targeting bromodomain recognition proteins. His work is crucial for advancing therapeutic options for various diseases.
Latest Patents
Yingqing Wang holds a patent for a dihydroquinoxaline bromodomain recognition protein inhibitor, along with its preparation method and uses. The invention relates to a compound represented by a specific general formula, which may include stereoisomers, pharmaceutically acceptable salts, prodrugs, solvates, hydrates, and crystal forms. This compound has the potential to inhibit bromodomain recognition proteins, thereby facilitating the development of medications that can regulate cellular states and treat diseases mediated by these proteins. He has 1 patent to his name.
Career Highlights
Yingqing Wang is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has garnered attention for its innovative approach to addressing complex biological challenges.
Collaborations
Yingqing Wang collaborates with notable colleagues, including Bing Xiong and Jingkang Shen, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yingqing Wang's contributions to the field of bromodomain recognition protein inhibitors highlight his role as a key innovator in medicinal chemistry. His work not only advances scientific understanding but also holds promise for future therapeutic developments.